<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635737"><TermName>BEACOPP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called BEACOPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722845" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;BEACOPP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722846" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen BEACOPP&quot;" language="es" id="_4"/><SpanishTermName>régimen BEACOPP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de  una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin en estadio avanzado. Incluye los siguientes medicamentos: sulfato de bleomicina, fosfato de etopósido, clorhidrato de doxorubicina (Adriamicina), ciclofosfamida,  sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama BEACOPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished><DateLastModified>2010-05-05</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000632570">BEACOPP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
